Prognostic value of nucleotide excision repair and translesion DNA synthesis proteins in muscle-infiltrating bladder carcinoma

Abstract Background Cisplatin (CDDP) remains a key agent in the treatment of muscle-infiltrating bladder carcinoma (MIBC). However, a proportion of MIBC patients do not respond to chemotherapy, which may be caused by the increased repair of CDDP-induced DNA damage. The purpose of this study was to e...

Full description

Bibliographic Details

Published in:	BMC Cancer
Main Authors:	Patrik Palacka, Andrea Holíčková, Jan Roška, Peter Makovický, Miroslava Vallová, Csaba Biró, Eveline Órásová, Jana Obertová, Jozef Mardiak, Thomas A. Ward, Karol Kajo, Miroslav Chovanec
Format:	Article
Language:	English
Published:	BMC 2024-09-01
Subjects:	Bladder carcinoma Muscle-infiltrating bladder carcinoma Cisplatin Gemcitabine DNA damage Nucleotide excision repair
Online Access:	https://doi.org/10.1186/s12885-024-12865-8